A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/00 (2006.01) A61K 31/5377 (2006.01) A61P 7/02 (2006.01) A61P 9/10 (2006.01)
Patent
CA 2596145
The present invention relates to the field of blood coagulation, more specifically it relates to a method of treating a thromboembolic disorder by administering once daily a direct factor Xa inhibitor in oral dosage form to a patient in need thereof, wherein the factor Xa inhibitor has a plasma concentration half life indicative of a bid or tid administration interval, e.g. of 10 hours or less.
La présente invention concerne le domaine de la coagulation sanguine, plus spécifiquement, une méthode de traitement d'un trouble thromboembolique par une seule administration quotidienne à un patient le nécessitant d'un inhibiteur du facteur Xa direct sous forme posologique orale, ledit inhibiteur du facteur Xa possédant une demi-durée de vie de concentration de plasma indiquant un intervalle d'administration de deux ou trois fois par jour, par ex. de dix heures tout au plus.
Kubitza Dagmar
Misselwitz Frank
Park Son-Mi
Wehling Klaus
Bayer Healthcare Ag
Bayer Schering Pharma Aktiengesellschaft
Fetherstonhaugh & Co.
LandOfFree
Prevention and treatment of thromboembolic disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prevention and treatment of thromboembolic disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prevention and treatment of thromboembolic disorders will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1959915